Charles River Laboratories International, Inc. (CRL) Revenue by Segment
Charles River Laboratories International revenue by segment at a glance
In Q2 fiscal 2026 (the quarter ended June 27, 2026), Charles River Laboratories International's largest business segment was Discovery and Safety Assessment, with $606.51 million or 60% of revenue, down 1.9% from a year earlier. Next: Research Models and Services (21%) and Manufacturing Support (19%).
By product or service, Service brought in 81% and Product brought in 19% of revenue in Q2 fiscal 2026.
By region, United States brought in 54%, Europe brought in 26% and Canada brought in 13% of revenue in Q2 fiscal 2026.
The fastest-growing business segment from a year earlier was Research Models and Services (-1.8%).
From company filings, in USD; latest quarter ended June 27, 2026; quarterly data from Q3 fiscal 2017.
Charles River Laboratories International, Inc.
Revenue breakdown
Fiscal quarters, from company filings
Charles River Laboratories International revenue by business segment, last 4 quarters
| Business segment | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| Discovery and Safety Assessment | $606.5M | $596.9M | $600.7M | $618.0M | 60% |
| Research Models and Services | $209.5M | $208.4M | $213.5M | $213.3M | 21% |
| Manufacturing Support | $188.1M | $190.5M | $190.7M | $200.8M | 19% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
Charles River Laboratories International revenue by product or service, last 4 quarters
| Product or service | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| Service | $808.3M | $798.2M | $808.0M | $840.8M | 81% |
| Product | $195.8M | $197.7M | $196.8M | $191.3M | 19% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
Charles River Laboratories International revenue by region, last 4 quarters
| Region | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| United States | $539.9M | $543.8M | $537.6M | $549.9M | 54% |
| Europe | $263.1M | $277.6M | $277.7M | $281.9M | 26% |
| Canada | $127.5M | $109.6M | $116.8M | $135.6M | 13% |
| Asia Pacific | $60.5M | $55.5M | $51.7M | $54.5M | 6% |
| Other | $13.1M | $9.4M | $21.1M | $10.3M | 1% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
Questions and answers
What are Charles River Laboratories International's business segments?
Discovery and Safety Assessment, Research Models and Services and Manufacturing Support (as reported for Q2 fiscal 2026).
Which business segment makes the most money for Charles River Laboratories International?
Discovery and Safety Assessment: $606.51 million, or 60% of revenue, in Q2 fiscal 2026.
What are Charles River Laboratories International's main products and services?
By revenue in Q2 fiscal 2026: Service (81%) and Product (19%).
Where does Charles River Laboratories International make its money?
By region in Q2 fiscal 2026: United States (54%), Europe (26%), Canada (13%) and Asia Pacific (6%).
